CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) - USD ($)	Preferred Stock Series B Preferred Stock	Preferred Stock	Common Stock	Additional Paid-In Capital	Common Stock Subscription Receivable From Related Party	Accumulated Deficit	Total
Beginning Balance at Feb. 10, 2020
Beginning Balance (in shares) at Feb. 10, 2020
Common stock issued for intellectual property			$ 6,254	(5,954)			300
Common stock issued for intellectual property (in shares)			62,531,965
Common stock subscription receivable from related party			$ 1,100	548,900	(550,000)
Common stock subscription receivable from related party (in shares)			11,000,000
Sales of common stock			$ 502	149,498			150,000
Sales of common stock (in share)			5,023,800
Common stock issued for services			$ 60	17,854			17,914
Common stock issued for services (in shares)			600,000
Stock issued in connection with reverse acquisition transaction	$ 72	$ 202	$ 781	8,314			9,369
Stock issued in connection with reverse acquisition transaction (in shares)	1,362	1,434	7,808,867
Stock-based compensation expense
Net Income (Loss)						(288,123)	(288,123)
Ending Balance at Apr. 30, 2020	$ 72	$ 202	$ 8,697	718,612	(550,000)	(288,123)	(110,540)
Ending Balance (in shares) at Apr. 30, 2020	1,362	1,434	86,964,632
Beginning Balance at Jul. 31, 2020	$ 72	$ 202	$ 9,669	1,456,644	(550,000)	(1,066,928)	(150,341)
Beginning Balance (in shares) at Jul. 31, 2020	1,347	1,434	96,691,761
Payments received on common stock subscription receivable from related party					67,400		67,400
Conversion of unsecured convertible promissory note payable			$ 13	25,669			25,682
Conversion of unsecured convertible promissory note payable (in share)			128,410
Sales of common stock			$ 1,320	658,680			660,000
Sales of common stock (in share)			13,200,000
Stock-based compensation expense				22,239			22,239
Net Income (Loss)						(477,730)	(477,730)
Ending Balance at Oct. 31, 2020	$ 72	$ 202	$ 11,002	2,163,232	(482,600)	(1,544,658)	147,250
Ending Balance (in shares) at Oct. 31, 2020	1,347	1,434	110,020,171
Beginning Balance at Jul. 31, 2020	$ 72	$ 202	$ 9,669	1,456,644	(550,000)	(1,066,928)	(150,341)
Beginning Balance (in shares) at Jul. 31, 2020	1,347	1,434	96,691,761
Common stock issued for services
Stock-based compensation expense							66,717
Net Income (Loss)							(916,137)
Ending Balance at Apr. 30, 2021	$ 72	$ 202	$ 12,627	3,879,095	(482,600)	(1,983,065)	1,426,331
Ending Balance (in shares) at Apr. 30, 2021	1,347	1,434	126,270,171
Beginning Balance at Oct. 31, 2020	$ 72	$ 202	$ 11,002	2,163,232	(482,600)	(1,544,658)	147,250
Beginning Balance (in shares) at Oct. 31, 2020	1,347	1,434	110,020,171
Sales of common stock			$ 1,125	1,123,875			1,125,000
Sales of common stock (in share)			11,250,000
Stock-based compensation expense				22,239			22,239
Discount on convertible promissory note payable				48,010			48,010
Net Income (Loss)						(522,673)	(522,673)
Ending Balance at Jan. 31, 2021	$ 72	$ 202	$ 12,127	3,357,356	(482,600)	(2,067,331)	819,826
Ending Balance (in shares) at Jan. 31, 2021	1,347	1,434	121,270,171
Sales of common stock			$ 500	499,500			500,000
Sales of common stock (in share)			5,000,000
Stock-based compensation expense				22,239			22,239
Net Income (Loss)						84,266	84,266
Ending Balance at Apr. 30, 2021	$ 72	$ 202	$ 12,627	$ 3,879,095	$ (482,600)	$ (1,983,065)	$ 1,426,331
Ending Balance (in shares) at Apr. 30, 2021	1,347	1,434	126,270,171